Bausch Health Secures Massive $600 Million Post-IPO Debt Funding

Key Takeaways: Pharmaceutical industry titan, Bausch Health, has just announced a colossal $600 million in Post-IPO Debt funding, further bolstering its position in the biotechnology and healthcare sector. Kohlberg Kravis Roberts, a globally recognized investment firm, led this round of funding, showcasing…

« read »